Proton pump inhibitors and the kidney: Critical review

Clinical Nephrology

Volumn 68, Issue 2, 2007, Pages 65-72

  Brewster, U C ^a   Perazella, Mark A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute interstitial nephritis; Acute kidney injury; Chronic kidney disease; Hyponatremia; Proton pump inhibitors

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOCHROME P450 2C19; ESOMEPRAZOLE; LANSOPRAZOLE; METICILLIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PREDNISONE; PROTON PUMP INHIBITOR; RABEPRAZOLE; SODIUM; STEROID; TACROLIMUS; VASOPRESSIN;

CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL DISEASE; GENETIC POLYMORPHISM; HEMATURIA; HUMAN; HYPONATREMIA; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FUNCTION; MALAISE; PHARMACODYNAMICS; PROGNOSIS; PROTEINURIA; REVIEW; STOMACH ACID SECRETION; VASOPRESSIN RELEASE; WATER DEPRIVATION;

EID: 34547828151     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp68065     Document Type: Review

References (38)

1. Assouad M, Vicks SL, Pokroy MV, Willcourt RJ. Recurrent acute interstitial nephritis on rechallenge with omeprazole. Lancet. 1994; 344: 549.
2. Brewster UC, Perazella MA. Acute kidney injury following proton pump inhibitor therapy. Kidney Int. 2007; 71: 589-593.
3. Buysen JG, Houthoff HJ, Krediet RT, Arisz L. Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant. 1990; 5: 94-99.
4. Castot A, Bidault I, Dahan R, Efthymiou ML. Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months. Therapie. 1993; 48: 469-474.
5. Christensen PB, Albertsen KE, Jensen P. Renal failure after omeprazole. Lancet 1993; 341: 55.
6. Christians U, Schmidt G, Bader A, Lampen A, Schottmann R, Linck A, Sewing KF. Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes. Br J Clin Pharmacol. 1996; 41: 187-190.
7. Clarkson MR, Giblin L, O'Connell FP, O'Kelly P, Walshe JJ, Conlon P, O'Meara Y, Dormon A, Campbell E, Donohoe J. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 2004; 19: 2778-2783.
8. Davison AM, Jones CH. Acute interstitial nephritis in the elderly: a report from the UK MRC Glomerulonephritis Register and a review of the literature. Nephrol Dial Transplant. 1998; 13 (Suppl 7): 12-16.
9. Durst RY, Pipek R, Levy Y. Hyponatremia caused by omeprazole treatment. Am J Med. 1994; 97: 400-401.
10. Farrington K, Levison DA, Greenwood RN, Cattell WR, Baker LR. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med. 1989; 70: 221-233.
11. Geetha D. Omeprazole-induced acute interstitial nephritis. Am J Gastroenterol. 1999; 94: 3375-3376.
12. Geevasinga N, Coleman PL, Roger SD. Rabeprazole-induced acute interstitial nephritis. Nephrology. 2005; 10: 7-9.
13. Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Chin Gastroenterol Hepatol. 2006; 4: 597-604.
14. Gonthier R, Bouchou K, Guy C, Cathebras P, Rousset H. Severe hyponatremia induced by omeprazole. Presse Med. 1993; 22: 176.
15. Green GA. Understanding NSAIDs: from aspirin to Cox-2. Clin Cornerstone. 2001; 3: 50-60.
16. Gronich JHSE, Stein HD, Sirota RA, Yudis M. Omeprazole related acute interstitial nephritis (AIN) with omeprazole. JASN. 1994; 5 (Abstract): 394.
17. Harmark L, van der Wiel HE, Mark CH, van Grootheest AC. Proton pump inhibitor induced acute interstitial nephritis. Br J Clin Pharmacol. 2007; in press
18. Howden CW, Reid JL. Omeprazole, a gastric proton pump inhibitor: lack of effect on renal handling of electrolytes and urinary acidification. Eur J Clin Pharmacol 1984; 26: 639-640.
19. Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors - emphasis on rabeprazole. Aliment Pharmacol Ther. 1999; 13 (Suppl 3): 27-36.
20. Itagaki F, Homma M, Yuzawa K, Fukao K, Kohda Y. Drug interaction of tacrolimnus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation. Transplant Proc. 2002; 34: 2777-2778.
21. Kaloustian E, Veyssier P. Severe hyponatremia: possible role of omeprazole. Presse Med. 1992; 21: 907-908.
22. Lorf T, Ramadori G, Ringe B, Schworer H. Pantoprazole does not affect cyclosporin A blood concentration in kidney-transplant patients. Eur J Clin Pharmacol. 2000; 55: 733-735.
23. Melville C, Shah A, Matthew D, Milla P. Electrolyte disturbance with omeprazole therapy. Eur J Pediatr. 1994; 153: 49-51.
24. Mennecier D, Ceppa F, Gidenne S, Vergeau B. Hyponatremia with consciousness disturbance associated with esomeprazole. Ann Pharmacother. 2005; 39: 774-775.
25. Myers RP, McLaughlin K, Hollomby DJ. Acute interstitial nephritis due to omeprazole. Am J Gastroenterol. 2001; 96: 3428-3431.
26. Pascual J, Marcen R, Orea OE, Navarro M, Alarcon MC, Ocana J, Villafruela JJ, Burgos FJ, Ortuno J. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study. Transplant Proc. 2005; 37: 3752-3753.
27. Physicians Desk Reference. 61st ed. Montvale, NJ: Thompson PDR; 2007.
28. Portera-Cailliau CSA. Acute interstitial nephritis due to omeprazole. Annals of Long-Term Care. 1999; 7: 206-207.
29. PostATVG, Zanen AL. Reversible renal failure after treatment with omeprazole. Neth J Med. 2000; 57: 58-61.
30. Preddie DC, Markowitz GS, Radhakrishnan J, Nickolas TL, D'Agati VD, Schwimmer JA, Gardenswartz M, Rosen R, Appel GB. Mycophenolate mofetil for the treatment of interstitial nephritis. J Am Soc Nephrol. 2006; 11: 718-722.
31. Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q J Med. 1983; 206: 194-211.
32. Ra A, Tobe SW. Acute interstitial nephritis due to pantoprazole. Ann Pharmacother. 2004; 38: 41-45.
33. Ruffenach SJ, Siskind MS, Lien YH. Acute interstitial nephritis due to omeprazole. Am J Med 1992; 93: 472-473.
34. Shiba S, Sugiura K, Ebata A, Kagaya T, Tomori G, Marumo F, Sato C. Hyponatremia with consciousness disturbance caused by omeprazole administration. A case report and literature review. Dig Dis Sci 1996; 41: 1615-1617.
35. Simpson IJMM, Pilmore H, Manley P, Williams L, Thein H, Voss D. Proton pump inhibitor and acute interstitial nephritis: report and analysis of 15 cases. Nephrology 2006; 11: 381-385.
36. Torpey N, Barker T; Ross C. Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unit. Nephrol Dial Transplant. 2004; 19: 1441-1446.
37. Torregrosa E, Rovira RE, Calvo C, Hernandez-Jaras J, Maduell F, Garcia H. Acute interstitial nephritis associated with omeprazole therapy. Nefrologia. 2004; 24 (Suppl 3): 61-63.
38. Wall CA, Gaffney EF, Mellotte GJ. Hypercalcaemia and acute interstitial nephritis associated with omeprazole therapy. Nephrol Dial Transplant. 2000; 15: 1450-1452.